“…However, other studies have found decreased glutamate/Glx in ASD in regions including the ACC (Bernardi et al, 2011;van Elst, Maier, Fangmeier, & Endres, 2014) the basal ganglia (Horder et al, 2013); frontal and occipital cortex, the cerebellum (Devito et al, 2007) and white matter (Corrigan et al, 2013). Yet other studies have found no significant differences in glutamate / Glx levels between individuals with and without ASD in several different brain regions including parietal lobes (Horder et al, 2013;Page et al, 2006), frontal lobes (Horder et al, 2013) temporal lobes (Devito et al, 2007), and occipital lobes (Robertson, Ratai, & Kanwisher, 2015); the thalamus (Bernardi et al, 2011;Doyle-Thomas et al, 2014;Hardan et al, 2008); hippocampus (Joshi et al, 2012);and cerebellum (van Elst et al, 2014). Therefore, the literature regarding glutamate/Glx levels in ASD is mixed.…”